Financials

Discussions Technicals Seasonals

4161 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Bioptik Technology, Inc. engages in the research and development, manufacture, and sale of hyaluronic acid and skincare product. Its products include monitoring systems for blood glucose, uric acid and cholesterol. The company was founded on June 1, 1999 and is headquartered in Miaoli, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

4161 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company